G Bussolati Selected Research

Oxytocin Receptors (Oxytocin Receptor)

4/2004	Oxytocin and oxytocin receptors in cancer cells and proliferation.
9/2003	Improved radiotracing of oxytocin receptor-expressing tumours using the new [111In]-DOTA-Lys8-deamino-vasotocin analogue.
6/2001	111In-labeled 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid-lys(8)-vasotocin: a new powerful radioligand for oxytocin receptor-expressing tumors.
3/2001	Activation of functional oxytocin receptors stimulates cell proliferation in human trophoblast and choriocarcinoma cell lines.
1/2001	Biological relevance of oxytocin and oxytocin receptors in cancer cells and primary tumors.
7/2000	A plasmin-derived hexapeptide from the carboxyl end of osteocalcin counteracts oxytocin-mediated growth inhibition [corrected] of osteosarcoma cells.
3/2000	Oxytocin receptors in human adenocarcinomas of the endometrium: presence and biological significance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

G Bussolati Research Topics

Disease

16	Neoplasms (Cancer) 12/2007 - 03/2000
7	Carcinoma (Carcinomatosis) 04/2004 - 05/2000
6	Breast Neoplasms (Breast Cancer) 01/2008 - 01/2001
2	Thyroid Neoplasms (Thyroid Cancer) 01/2006 - 05/2001
2	Adenocarcinoma 09/2001 - 03/2000
2	Adenoma (Adenomas) 08/2001 - 09/2000
2	Endometrial Neoplasms (Endometrial Cancer) 06/2001 - 03/2000
1	Colorectal Neoplasms (Colorectal Cancer) 01/2013
1	Dehydration (Water Stress) 01/2012
1	Papillary Thyroid Cancer 01/2010
1	Ductal Carcinoma 10/2003
1	Neoplasm Metastasis (Metastasis) 03/2003
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2001
1	Malignant Mesothelioma 09/2001
1	Neuroendocrine Carcinoma 09/2001
1	Glioblastoma (Glioblastoma Multiforme) 06/2001
1	Neuroblastoma 06/2001
1	Thyroid Nodule (Nodule, Thyroid) 05/2001
1	Choriocarcinoma 03/2001
1	Hemangiosarcoma (Angiosarcoma) 12/2000
1	Noninfiltrating Intraductal Carcinoma (DCIS) 10/2000
1	Hyperplasia 09/2000
1	Secondary Hyperparathyroidism 09/2000
1	Osteosarcoma (Osteogenic Sarcoma) 07/2000
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 03/2000
1	Carcinoid Tumor (Carcinoid) 03/2000
1	Small Cell Carcinoma 03/2000
1	Asphyxia (Suffocation) 01/2000
1	HIV Infections (HIV Infection) 01/2000
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2000
1	Infections 01/2000

Drug/Important Bio-Agent (IBA)

7	Oxytocin Receptors (Oxytocin Receptor)IBA 04/2004 - 03/2000
5	Oxytocin (Pitocin)FDA LinkGeneric 04/2004 - 07/2000
4	Biological ProductsIBA 04/2004 - 03/2000
4	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 05/2002 - 03/2000
4	Messenger RNA (mRNA)IBA 01/2001 - 03/2000
3	Proteins (Proteins, Gene)FDA Link 10/2003 - 09/2000
3	Somatostatin Receptors (Somatostatin Receptor)IBA 05/2002 - 03/2000
2	ParaffinIBA 01/2012 - 03/2000
2	Trastuzumab (Herceptin)FDA Link 12/2007 - 04/2005
2	Galectin 3 (LGALS3)IBA 01/2006 - 05/2001
2	Indicators and Reagents (Reagents)IBA 04/2005 - 06/2001
2	Octreotide (Sandostatin)FDA LinkGeneric 12/2001 - 03/2000
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 12/2001 - 03/2000
2	Androgen Receptors (Androgen Receptor)IBA 08/2001 - 05/2001
1	Lamin B ReceptorIBA 01/2010
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2008
1	Nucleic AcidsIBA 12/2001
1	pentetreotide (OctreoScan)FDA Link 12/2001
1	AsbestosIBA 09/2001
1	AntigensIBA 09/2001
1	Keratins (Keratin)IBA 09/2001
1	CaspasesIBA 08/2001
1	Differentiation AntigensIBA 08/2001
1	Estrogen ReceptorsIBA 08/2001
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 06/2001
1	AcidsIBA 06/2001
1	Chelating AgentsIBA 06/2001
1	LigandsIBA 06/2001
1	Vasotocin (Argiprestocin)IBA 06/2001
1	Tyrosine (L-Tyrosine)FDA Link 03/2001
1	Peptides (Polypeptides)IBA 03/2001
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2001
1	Complement System Proteins (Complement)IBA 01/2001
1	Hormones (Hormone)IBA 01/2001
1	ChromograninsIBA 01/2001
1	SynaptophysinIBA 01/2001
1	Biogenic Amines (Biogenic Amine)IBA 01/2001
1	AndrogensIBA 01/2001
1	Thyroglobulin FDA Link 12/2000
1	Oxygen (Dioxygen)IBA 10/2000
1	SilverIBA 09/2000
1	Fibrinolysin FDA Link 07/2000
1	Plasminogen Activators (Plasminogen Activator)IBA 07/2000
1	OsteocalcinIBA 07/2000
1	Monoclonal AntibodiesIBA 03/2000
1	somatostatin receptor 2IBA 03/2000
1	Zidovudine (Retrovir)FDA LinkGeneric 01/2000
1	Surface-Active Agents (Surfactants)IBA 01/2000

Therapy/Procedure

5	Therapeutics 01/2013 - 01/2000
2	Cesarean Section (Caesarean Section) 01/2000 - 01/2000
1	Drug Therapy (Chemotherapy) 04/2005
1	Adjuvant Chemotherapy 03/2003